Outset Medical Inc - Common Stock (OM)

CUSIP: 690145107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
18,303,310
Total 13F shares
48,556,337
Share change
-4,122,404
Total reported value
$2,237,798,401
Put/Call ratio
21%
Price per share
$46.09
Number of holders
153
Value change
-$207,141,965
Number of buys
85
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 690145107?
CUSIP 690145107 identifies OM - Outset Medical Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OM - Outset Medical Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
38%
6,946,979
$343,458,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
26%
4,830,578
$238,821,000 30 Sep 2021
13F
D1 Capital Partners L.P.
13F
Company
25%
4,575,753
$226,225,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
22%
4,003,735
$197,945,000 30 Sep 2021
13F
PFM Health Sciences, LP
13F
Company
16%
2,966,712
$146,674,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
16%
2,840,613
$140,439,000 30 Sep 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
12%
2,276,036
$112,527,000 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
11%
2,101,939
$103,920,000 30 Sep 2021
13F
PERCEPTIVE ADVISORS LLC
13F
Company
11%
1,990,633
$98,417,000 30 Sep 2021
13F
Champlain Investment Partners, LLC
13F
Company
10%
1,866,480
$92,279,000 30 Sep 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
8.5%
1,550,932
$76,678,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
5.7%
1,034,464
$51,144,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
5.6%
1,019,034
$50,381,000 30 Sep 2021
13F
TimesSquare Capital Management, LLC
13F
Company
5.5%
1,014,560
$50,160,000 30 Sep 2021
13F
JENNISON ASSOCIATES LLC
13F
Company
5.5%
1,011,164
$49,992,000 30 Sep 2021
13F
RTW INVESTMENTS, LP
13F
Company
4.9%
894,652
$44,232,000 30 Sep 2021
13F
FIL Ltd
13F
Company
4.6%
834,751
$41,270,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4%
730,255
$36,103,000 30 Sep 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
3%
541,192
$26,757,000 30 Sep 2021
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
2.6%
467,115
$23,094,000 30 Sep 2021
13F
Bellevue Group AG
13F
Company
2.5%
457,060
$22,597,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
2.4%
440,652
$21,785,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
2.4%
437,524
$21,632,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
2.3%
428,442
$21,184,000 30 Sep 2021
13F
WASATCH ADVISORS LP
13F
Company
2.3%
416,511
$20,592,000 30 Sep 2021
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
2.2%
400,622
$19,807,000 30 Sep 2021
13F
Eagle Health Investments LP
13F
Company
1.8%
332,800
$16,454,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.6%
292,327
$14,453,000 30 Sep 2021
13F
LORD, ABBETT & CO. LLC
13F
Company
1.2%
220,995
$10,926,000 30 Sep 2021
13F
Woodline Partners LP
13F
Company
1.1%
208,179
$10,292,000 30 Sep 2021
13F
GAM Holding AG
13F
Company
1.1%
194,100
$9,596,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.89%
163,074
$8,966,000 30 Sep 2021
13F
STRS OHIO
13F
Company
0.88%
160,600
$7,940,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.76%
139,894
$6,917,000 30 Sep 2021
13F
Neuberger Berman Group LLC
13F
Company
0.72%
131,548
$6,383,000 30 Sep 2021
13F
S.c.a. Candriam
13F
Individual
0.65%
118,555
$5,861,000 30 Sep 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.61%
111,858
$5,530,000 30 Sep 2021
13F
BRR OpCo, LLC
13F
Company
0.61%
110,823
$5,479,000 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.52%
95,878
$4,740,000 30 Sep 2021
13F
Swiss National Bank
13F
Company
0.47%
86,400
$4,272,000 30 Sep 2021
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.44%
80,400
$3,975,000 30 Sep 2021
13F
TD ASSET MANAGEMENT INC
13F
Company
0.44%
80,147
$3,962,000 30 Sep 2021
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.43%
78,108
$3,862,000 30 Sep 2021
13F
Crestline Management, LP
13F
Company
0.39%
72,176
$3,568,000 30 Sep 2021
13F
Walleye Capital LLC
13F
Company
0.39%
70,956
$3,508,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.35%
64,585
$3,193,000 30 Sep 2021
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.35%
64,410
$3,184,000 30 Sep 2021
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.34%
62,032
$3,067,000 30 Sep 2021
13F
Holocene Advisors, LP
13F
Company
0.34%
62,024
$3,066,000 30 Sep 2021
13F
Ensign Peak Advisors, Inc
13F
Company
0.32%
57,892
$2,862,000 30 Sep 2021
13F

Institutional Holders of Outset Medical Inc - Common Stock (OM) as of Q4 2021

As of 31 Dec 2021, Outset Medical Inc - Common Stock (OM) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,556,337 shares. The largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, PFM Health Sciences, LP, ALLIANCEBERNSTEIN L.P., Allspring Global Investments Holdings, LLC, Champlain Investment Partners, LLC, PERCEPTIVE ADVISORS LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 153 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
138
Q4 2021 holders
153
Holder diff
15
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.